George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Crow. I did say. Sushi. I think you’ll find the Cancer studies are the ones pivotal at phase 2 and others at 3. Due to the fact those studies can see results in phase 1
Promoting their side effects. OAK. Very impressive
It’s a night out for the boys. I’m going to one in Nice next week. Already know everything that’s on the agenda. Nice hotel, food, drinks all paid for by sponsor. What’s not to like. Apart from the chit chat you have to put up with at these events.
It’s pretty much a confirmation. Don’t tell the boom boys that. Nothings really changed. Avacta is still definitely worth a punt all the same.
Yes CT. Cancer phase 2, especially in this case with concentrating on a specific tumour type. Is like choosing the right distance for your race horse. It increases their odds and limits the chance of failure.
They wouldn’t get to phase 2 without the results. Lol. Maybe you didn’t know that
The reduction in side effects figures are greater than they expected. Very impressive.
Sale or collaboration.
Could be as quick as early 2025 for phase 2. Where the results really matter and possible
Exactly Dougie. The man at the helm spouting £50m mcap at the time of the hugely anticipated Leap sale. No…..That’s not misleading at all. Crooks
The whole deal was ridiculous. A company with a £6billion mcap buys a tiny £14 mcap company and pays half upfront and half in a years time. What the hell is that all about.
No Daprophet. I’ve exposed his and Doggos and wadnobs lies over the years. Q got me taken off here.
My biggest bugbear was the moon deal. Sold at a pittance when they had revenue even then in the 10s millions each month. seed would have a £500m mcap now with moon.
Factor. They couldn’t close a raise. All investors refused to give them any money and yet Seed the smallest investor in Factom gave them ( their buddies ) £5m. Later to be written off. Yooya , then Yooma. Just one of its change of names and over £3m invested into their buddies play thing. Also written off. The whole company has been a disaster. No wonder Jim and Lorne had to get their names off the Bod as quick as. Ed’s £50m mcap talk. lol. The list goes on.
Longlad / Fatman. Spot on. Ed could never raise again. Imagine he invests all the cash and they have to do a raise to keep the payroll. Who on earth would invest. No buyers at 2p when the nav is 6p. They would have to raise at a massive discount to 2p and even then I don’t see any takers.
I’ve been here in a different form myself until the same guy got me removed for revealing his past. Been here before the likes of doggy and wadnob. Gave my feeling about the shady moon deal and many others.
Ahh. lol. I think I know the fraudster you are talking about. He’s been in and out more times than John holmes Disappears when he is outed each time
Syn ? Don’t own any syn or have any interest. Maybe somebody else?
Wouldn’t be surprised for them to say it had been reduced to……..due to the condition that Ed hasn’t managed even one good investment.
The second tranche of sale proceeds, being €2.8 million (calculated as the remaining 50% of the sale proceeds and subject only to any claims under customary warranties & indemnities,), is expected to be received in April 2024,
Remember the second payment was conditional. I wouldn’t be surprised if they come back with some excuse. They are pretty good at that
It’s the usual pump and dump. I can’t respond on there as it is my work account. They are twisting things to say the least. All in all Avacta does look very promising but these folks want to hype it and then get out before the fall. Enjoy the weekend and wait for real news. ( though twitter does often provide a nice increase on pure ramp ) Off to enjoy the Sun.
Though they still obviously have to go through phase 3 prior to FDA approval. I’ve recently sat on a SSV for an FDA approved study and the PI’s couldn’t believe how many errors there were in the Protocol. So many that they had to contact them to stop the study in the US. That had already started. The FDA often approve drugs in the US often many months or even years before they are approved for use in the UK. It is changing so if approved by the FDA it can then be used in the UK. This reciprocal agreement could boost the Pharma’s enormously. This is often overlooked by investors.
Sushi. I think you’ll find the Cancer studies are the ones pivotal at phase 2 and others at 3. Due to the fact those studies can see results in phase 1